Repost: Rife Cancer Virus may be Bacillus licheniformis Next item Energy Balancing by Numbers

Repost: Rife Cancer Virus may be Bacillus licheniformis

Update:  This original Rife organism appears to be a necessary condition for cancer cells to survive. There are many strains of this organism and it is very persistent.



The Rife BX/BY “virus” was probably not a virus but a filterable, polymorphic, cell-wall deficient bacteria like Bacillus licheniformus. In this regard, it appears similar to the Gregory cancer “virus” which duplicates by cell replication, clearly not a virus. Both of the organisms are found in every cancer patient.

Virtually all people with cancer are infected with bacillus lichenformis. The first step in dealing with cancer electronically must be to eliminate all bacillus lichenformis from the body as it appears to be both a tumor promoter and a mutagen. Tumors will tend to grow or recur with this organism present.

Many researchers have not seen the note in Lancet, one of the leading medical journals, where scientists claimed to have DNA sequenced the “cancer germ.” What appears to be the Rife “filterable bacteria” was isolated and DNA sequenced by British researchers. Bacillus licheniformis is a pleomorphic organism that appears as rods, cocci, and fungus-like forms. Rife had a very difficult time culturing this organism in the 1920’s and people have had limited success since then, so demonstrating non-contaminated multiple forms of the same organism with exactly the same DNA sequence is a major accomplish that could end decades of controversy.

Sansom, Clare. “Cancer Germ” Bacteria Isolated. THE LANCET Oncology, Vol 4 February 2003, p. 63.
(You will need to create a free Lancet account to view this document.)

Milton Wainwright had already published data previously showing bacteria can pass through very small holes (as noted by Rife) and that this has major implications for their role as pathogens. See: Med Hypotheses 2002 Jun;58(6):558-60.

In my view, scanning and eliminating this bacterium in the general population could reduce the incidence of cancer and improve survival of cancer patients by more than 50%. This is based on my on my own research and that of hundreds of investigators trying to replicate Rife’s early work on successful treatment of cancer patients with electronic devices.

Add Your Comment

Your email address will not be published. Required fields are marked *